225 related articles for article (PubMed ID: 19541367)
1. CD19 signaling is impaired in murine peritoneal and splenic B-1 B lymphocytes.
Dasu T; Sindhava V; Clarke SH; Bondada S
Mol Immunol; 2009 Aug; 46(13):2655-65. PubMed ID: 19541367
[TBL] [Abstract][Full Text] [Related]
2. CD19 amplifies B lymphocyte signal transduction by regulating Src-family protein tyrosine kinase activation.
Fujimoto M; Poe JC; Jansen PJ; Sato S; Tedder TF
J Immunol; 1999 Jun; 162(12):7088-94. PubMed ID: 10358152
[TBL] [Abstract][Full Text] [Related]
3. CD19 amplification of B lymphocyte Ca2+ responses: a role for Lyn sequestration in extinguishing negative regulation.
Fujimoto M; Poe JC; Hasegawa M; Tedder TF
J Biol Chem; 2001 Nov; 276(48):44820-7. PubMed ID: 11584010
[TBL] [Abstract][Full Text] [Related]
4. A CD19-dependent signaling pathway regulates autoimmunity in Lyn-deficient mice.
Hasegawa M; Fujimoto M; Poe JC; Steeber DA; Lowell CA; Tedder TF
J Immunol; 2001 Sep; 167(5):2469-78. PubMed ID: 11509585
[TBL] [Abstract][Full Text] [Related]
5. CD19 regulates innate immunity by the toll-like receptor RP105 signaling in B lymphocytes.
Yazawa N; Fujimoto M; Sato S; Miyake K; Asano N; Nagai Y; Takeuchi O; Takeda K; Okochi H; Akira S; Tedder TF; Tamaki K
Blood; 2003 Aug; 102(4):1374-80. PubMed ID: 12714520
[TBL] [Abstract][Full Text] [Related]
6. Cd19-dependent activation of Akt kinase in B-lymphocytes.
Otero DC; Omori SA; Rickert RC
J Biol Chem; 2001 Jan; 276(2):1474-8. PubMed ID: 11042164
[TBL] [Abstract][Full Text] [Related]
7. Defective CD19-dependent signaling in B-1a and B-1b B lymphocyte subpopulations.
Sen G; Wu HJ; Bikah G; Venkataraman C; Robertson DA; Snow EC; Bondada S
Mol Immunol; 2002 Sep; 39(1-2):57-68. PubMed ID: 12213328
[TBL] [Abstract][Full Text] [Related]
8. CD19 differentially regulates BCR signalling through the recruitment of PI3K.
Xu Y; Fairfax K; Light A; Huntington ND; Tarlinton DM
Autoimmunity; 2014 Nov; 47(7):430-7. PubMed ID: 24953501
[TBL] [Abstract][Full Text] [Related]
9. The activation and subsequent regulatory roles of Lyn and CD19 after B cell receptor ligation are independent.
Xu Y; Beavitt SJ; Harder KW; Hibbs ML; Tarlinton DM
J Immunol; 2002 Dec; 169(12):6910-8. PubMed ID: 12471124
[TBL] [Abstract][Full Text] [Related]
10. c-Abl-deficient mice exhibit reduced numbers of peritoneal B-1 cells and defects in BCR-induced B cell activation.
Liberatore RA; Goff SP
Int Immunol; 2009 Apr; 21(4):403-14. PubMed ID: 19228876
[TBL] [Abstract][Full Text] [Related]
11. CD19 controls Toll-like receptor 9 responses in human B cells.
Morbach H; Schickel JN; Cunningham-Rundles C; Conley ME; Reisli I; Franco JL; Meffre E
J Allergy Clin Immunol; 2016 Mar; 137(3):889-98.e6. PubMed ID: 26478008
[TBL] [Abstract][Full Text] [Related]
12. TRAF5 is a critical mediator of in vitro signals and in vivo functions of LMP1, the viral oncogenic mimic of CD40.
Kraus ZJ; Nakano H; Bishop GA
Proc Natl Acad Sci U S A; 2009 Oct; 106(40):17140-5. PubMed ID: 19805155
[TBL] [Abstract][Full Text] [Related]
13. CD19 and BAFF-R can signal to promote B-cell survival in the absence of Syk.
Hobeika E; Levit-Zerdoun E; Anastasopoulou V; Pohlmeyer R; Altmeier S; Alsadeq A; Dobenecker MW; Pelanda R; Reth M
EMBO J; 2015 Apr; 34(7):925-39. PubMed ID: 25630702
[TBL] [Abstract][Full Text] [Related]
14. Tyrosine phosphorylation of B-cell adaptor for phosphoinositide 3-kinase is required for Akt activation in response to CD19 engagement.
Inabe K; Kurosaki T
Blood; 2002 Jan; 99(2):584-9. PubMed ID: 11781242
[TBL] [Abstract][Full Text] [Related]
15. Differential phosphorylation of functional tyrosines in CD19 modulates B-lymphocyte activation.
Ishiura N; Nakashima H; Watanabe R; Kuwano Y; Adachi T; Takahashi Y; Tsubata T; Okochi H; Tamaki K; Tedder TF; Fujimoto M
Eur J Immunol; 2010 Apr; 40(4):1192-204. PubMed ID: 20101619
[TBL] [Abstract][Full Text] [Related]
16. Phosphorylation of CD19 Y484 and Y515, and linked activation of phosphatidylinositol 3-kinase, are required for B cell antigen receptor-mediated activation of Bruton's tyrosine kinase.
Buhl AM; Cambier JC
J Immunol; 1999 Apr; 162(8):4438-46. PubMed ID: 10201980
[TBL] [Abstract][Full Text] [Related]
17. Integration of activatory and inhibitory signals in human B-cells.
Sármay G; Koncz G; Gergely J
Immunol Lett; 1996 Dec; 54(2-3):93-100. PubMed ID: 9052860
[TBL] [Abstract][Full Text] [Related]
18. Vav-dependent and vav-independent phosphatidylinositol 3-kinase activation in murine B cells determined by the nature of the stimulus.
Vigorito E; Bardi G; Glassford J; Lam EW; Clayton E; Turner M
J Immunol; 2004 Sep; 173(5):3209-14. PubMed ID: 15322182
[TBL] [Abstract][Full Text] [Related]
19. Regulation of MHC class II signal transduction by the B cell coreceptors CD19 and CD22.
Bobbitt KR; Justement LB
J Immunol; 2000 Nov; 165(10):5588-96. PubMed ID: 11067914
[TBL] [Abstract][Full Text] [Related]
20. Interleukin-4 overcomes the negative influence of cyclic AMP accumulation on antigen receptor stimulated B lymphocytes.
Venkataraman C; Chelvarajan RL; Cambier JC; Bondada S
Mol Immunol; 1998 Oct; 35(14-15):997-1014. PubMed ID: 9881695
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
